Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
Updated Oct. 23, 2023 6:55 am ETRoche Holding has agreed to buy the developer of a bowel-disease treatment from Roivant...
ROG.EB
Biotech Stocks, Once Booming, Enter Bear Territory
Biotech companies are having one of their worst stock-market runs in years, as rising interest rates, scientific setbacks and a...
Toshiba Shareholders Oust Chairman in Landmark for Foreign Activists
TOKYO— Toshiba Corp.’s TOSYY 0.18% chairman was ousted in a vote at the company’s annual meeting, a milestone in Japanese...
FTC Seeks to Block Illumina’s $7.1 Billion Acquisition of Life Sciences Firm Grail
WASHINGTON—The Federal Trade Commission filed suit Tuesday to block Illumina Inc.’s planned $7.1 billion acquisition of a company developing an...
